Called Pro-DG , the ingredient is being marketed as having particularly good slimming properties for the thighs and middle area in its target category, which is body care.
Launched at the recent Cosmetagora 2013 event, Soliance says that the ingredient was developed in answer to the fact that, with time, the body is exposed to a variety of internal and external factors that affect the body shape.
Targeting loss of body shape
Ultimately these factors lead to the storage of fat cells that can lead to the ‘loss of body shape’, which is what this new ingredient targets.
Pro-DG has been developed using a microalgae called Dysmorphococcus globosos, which is known to break down fat cells and contribute to slimming, the company says.
The Soliance research team says that it has developed a product that has a dual action slimming effect which has efficacy that has been proven in clinical trials.
Targeting lipids storage and stimulation of lipolysis
This dual action firstly targets lipids storage by preventing the triglycerides synthesis, and secondly promotes the stimulation of lipolysis by stimulating the cAMP rate and glycerol release.
The research team says that clinical trials prove the ingredient inhibits the synthesis of triglycerides by up to 85 per cent, leading to the visible reduction of adipocyte size within seven days, ultimately leading to a 1.5cm reduction in the circumference of the thigh within 56 days.
Developed using biotechnology, ex vivo and in vivo tests demonstrate that a 3 per cent dose of the active is sufficient for cosmetic formulas and is suitable for all skin types.